HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium.

Abstract
Tissue damage after stroke is partly due to disruption of the blood-brain barrier (BBB). Little is known about the role of calcium in modulating BBB disruption. We investigated the effect of hypoxic and aglycemic stress on BBB function and intracellular calcium levels. Bovine brain microvessel endothelial cells were treated with A-23187 to increase intracellular calcium without hypoxia or treated with a calcium chelator (BAPTA) or calcium channel blockers (nifedipine or SKF-96365) and 6 h of hypoxia. A-23187 alone did not increase paracellular permeability. Hypoxia increased intracellular calcium, and hypoxia or hypoxia-aglycemia increased paracellular permeability. Treatment with nifedipine and SKF-96365 increased intracellular calcium under normoglycemic conditions, instead of blocking calcium influx, and was protective against hypoxia-induced BBB disruption under normoglycemia. Protection by nifedipine and SKF-96365 was not due to antioxidant properties of these compounds. These data indicate that increased intracellular calcium alone is not enough to disrupt the BBB. However, increased intracellular calcium after drug treatment and hypoxia suggests a potential mechanism for these drugs in BBB protection; nifedipine and SKF-96365 plus hypoxic stress may trigger calcium-mediated signaling cascades, altering BBB integrity.
AuthorsRachel C Brown, Karen S Mark, Richard D Egleton, Thomas P Davis
JournalAmerican journal of physiology. Cell physiology (Am J Physiol Cell Physiol) Vol. 286 Issue 5 Pg. C1045-52 (May 2004) ISSN: 0363-6143 [Print] United States
PMID15075203 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antioxidants
  • Calcium Channel Blockers
  • Chelating Agents
  • Imidazoles
  • Ionophores
  • Calcimycin
  • Egtazic Acid
  • 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole
  • Nifedipine
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
  • Calcium
Topics
  • Animals
  • Antioxidants (pharmacology)
  • Blood-Brain Barrier (drug effects)
  • Calcimycin (pharmacology)
  • Calcium (metabolism)
  • Calcium Channel Blockers (pharmacology)
  • Cattle
  • Cell Membrane Permeability (drug effects)
  • Cells, Cultured
  • Chelating Agents (pharmacology)
  • Egtazic Acid (analogs & derivatives, pharmacology)
  • Endothelium, Vascular (drug effects, metabolism)
  • Hypoxia (metabolism, physiopathology)
  • Imidazoles (pharmacology)
  • Intracellular Fluid (metabolism)
  • Ionophores (pharmacology)
  • Nifedipine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: